Real-world and trial-based cost-effectiveness analysis of bevacizumab in HER2-negative metastatic breast cancer patients: a study of the Southeast Netherlands Breast Cancer Consortium
| Image |  |
|---|---|
| Description | scientific article published on 25 February 2017 |
| Author/s |
author: Bram Ramaekers Agnes van de Wouw Tineke J Smilde Manuela A Joore |
| Publication date | February 25, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |